Brain-computer interface companies are no longer an emerging category; they are an arriving one. As of 2026, multiple invasive BCI systems are operating inside living human patients, non-invasive devices are entering consumer markets, and the convergence of artificial intelligence with neural signal decoding is producing capability improvements that no single hardware generation could achieve alone. This article maps the 20 most consequential brain-computer interface companies operating...